Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP285954.RA7l__DokR6E7YuwV5SN141PHcFsBboGb7HCnsHNqEd5g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP285954.RA7l__DokR6E7YuwV5SN141PHcFsBboGb7HCnsHNqEd5g130_assertion type Assertion NP285954.RA7l__DokR6E7YuwV5SN141PHcFsBboGb7HCnsHNqEd5g130_head.
- NP285954.RA7l__DokR6E7YuwV5SN141PHcFsBboGb7HCnsHNqEd5g130_assertion description "[TET2 mutations were not associated with outcomes in the ELN intermediate-I-risk group (CN-AML with wild-type CEBPA and wild-type NPM1 and/or FLT3-ITD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP285954.RA7l__DokR6E7YuwV5SN141PHcFsBboGb7HCnsHNqEd5g130_provenance.
- NP285954.RA7l__DokR6E7YuwV5SN141PHcFsBboGb7HCnsHNqEd5g130_assertion evidence source_evidence_literature NP285954.RA7l__DokR6E7YuwV5SN141PHcFsBboGb7HCnsHNqEd5g130_provenance.
- NP285954.RA7l__DokR6E7YuwV5SN141PHcFsBboGb7HCnsHNqEd5g130_assertion SIO_000772 21343549 NP285954.RA7l__DokR6E7YuwV5SN141PHcFsBboGb7HCnsHNqEd5g130_provenance.
- NP285954.RA7l__DokR6E7YuwV5SN141PHcFsBboGb7HCnsHNqEd5g130_assertion wasDerivedFrom befree-20140225 NP285954.RA7l__DokR6E7YuwV5SN141PHcFsBboGb7HCnsHNqEd5g130_provenance.
- NP285954.RA7l__DokR6E7YuwV5SN141PHcFsBboGb7HCnsHNqEd5g130_assertion wasGeneratedBy ECO_0000203 NP285954.RA7l__DokR6E7YuwV5SN141PHcFsBboGb7HCnsHNqEd5g130_provenance.